Finerenone group:Finerenone

4 trials

Sponsors

Drum Tower Hospital Affiliated to Nanjing University Medical School, The first medical center of Chinese PLA general hospital, Shanghai General Hospital, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

Conditions

Primary AldosteronismT2DM combined with CKDdiabetic cardiovascular autonomic neuropathypersistent atrial fibrillation

Phase 4

Compare the Efficacy and Safety of Finerenone, a New Type of Mineralocorticoid Receptor Antagonist, and Spironolactone in the Treatment of Primary Aldosteronism: a Single-Center, Prospective, Randomized Controlled Study

Active, not recruitingChiCTR2300069660

Drum Tower Hospital Affiliated to Nanjing University Medical SchoolPrimary Aldosteronism

Start: 2023-04-01Updated: 2023-05-29

A study on Efficacy and Safety of SGLT-2 Inhibitors Combined with Finerenone in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

Active, not recruitingChiCTR2500102004

The first medical center of Chinese PLA general hospitalT2DM combined with CKD

Start: 2025-05-08Updated: 2025-05-12

Unknown Phase

Efficacy and Safety of Finerenone in Diabetic Kidney Disease Patients with Cardiac Autonomic Neuropathy

Active, not recruitingChiCTR2500112473

Shanghai General Hospitaldiabetic cardiovascular autonomic neuropathy

Start: 2025-12-01Updated: 2025-11-17

Efficacy of Finerenone on Recurrence After Catheter Ablation for Atrial Fibrillation: FINE-AF trial

Active, not recruitingChiCTR2600131231

Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing Universitypersistent atrial fibrillation

Start: 2026-09-01Updated: 2026-09-07